Elevated levels of serum vascular endothelial growth factor in patients with polycythaemia vera

Acta Haematologica

Volumn 110, Issue 1, 2003, Pages 16-19

  Theodoridou, Stamatia ^a   Vyzantiadis, Timoleon ^a,b   Vakalopoulou, Sofia ^a   Perifanis, Vassilios ^a   Tziomalos, Konstantinos ^a   Vyzantiadis, Athanassios ^a   Garipidou, Vassilia ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University and Hippokration General Hospital   (Greece)

Author keywords

Angiogenesis; Chronic myeloproliferative disorders; Polycythaemia vera; Vascular endothelial growth factor

Indexed keywords

HEMOGLOBIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ASSAY; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEMOGLOBINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTE COUNT; LYMPHOKINES; MALE; MIDDLE AGED; PLATELET COUNT; POLYCYTHEMIA VERA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0141788393     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072408     Document Type: Article

References (21)

1. Mangi MH, Newland AC: Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol 2000;111:43-51.
2. Palmblad J: Angiogenesis in haematologic malignancies with focus on multiple myeloma. Haema 2001;4:89-98.
3. Dirix LY, Vermeulen PB, Pawinski A, Prove A, de Pooter C, Martin M: Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in the sera of cancer patients. Br J Cancer 1997;76:238-243.
4. Kraft A, Weindel K, Ochs A, Marth C, Zmija I, Schumacher P, Unger C, Marme D, Gastl G: Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 1999;85:178-187.
5. Salven P, Oprana A, Joensuu H: Leucocyte and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 1999;5:487-491.
6. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
7. Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM: Platelet: Transporter of vascular endothelial growth factor. Clin Cancer Res 1997; 3:2187-2190.
8. Wartiovaora U, Salven P, Mikkola H: Peripheral blood platelet express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 1998;80:171-175.
9. Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J: Bone marrow in polycythemia vera, chronic myelocytic leukaemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000;157:15-19.
10. Palmblad J, Lerner R, Lundberg LG: Vascular density, intracellular VEGF and b FGF positivity as prognostic factors in polycythemia vera and chronic myelocytic leukaemia. Blood 2000;96(suppl 1):257b.
11. Di Raimondo F, Palumbo GA, Molica S, Giustolisi R: Angiogenesis in chronic myeloproliferative diseases. Acta Haematol 2001;106:177-183.
12. Di Raimondo F, Azzaro MP, Palumbo GA, Bagnalo S, Stagno F, Giustolisi GM, Cacciola E, Sortino G, Guglielmo P, Giustolisi R: Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis. Leukemia 2001;15:976-980.
13. Musolino C, Calabro L, Bellomo G, Martello F, Loteta B, Pezzano C, Rizzo V, Allonci A: Soluble angiogenic factors: Implications for chronic myeloproliferative disorders. Am J Hematol 2002;69:159-163.
14. Cacciola RR, di Francesco E, Giustolisi R, Cassiola E: Elevated serum vascular endothelial growth factor levels in patients with polycythemia vera and thrombotic complications. Haematologica 2002;87:774-775.
15. Murphy P, Ahmed N, Hassan H: Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera. Leuk Res 2002;Nov 26(11):1007.
16. Pearson TC: Diagnosis and classification of erythrocytoses and thrombocytoses. Baillière's Clin Haematol 1998;11:695-720.
17. Mohle R, Green D, Moore MAS, Nachman RL, Rafii S: Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megacaryocytes and platelets. Proc Natl Acad Sci USA 1997;94:663-668.
18. Maloney JP, Silliman CC, Ambruso DR, Wan GJ, Tuder RM, Voelkei NF: In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998;275:H1054-1061.
19. Ogawa H, Yasue H, Misumi I, Masuda T, Okumura K, Banai S, Takanashi N, Tsukada Y: Plasma platelet-derived growth factor levels in coronary circulation in unstable angina pectoris. Am J Cardiol 1992;69:453-456.
20. Rossi E, Casali B, Regolisti G, Savoli S, Perazzoli F, Negro A, Sani C, Tumiati B, Nicoli D: Increased plasma levels of platelet-derived growth factor (PDGF-BB+PDGF-AB) in patients with never-treated mild essential hypertension. Am J Hypertens 1998;11:1239-1243.
21. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ: Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956-964.